Quote (thundercock @ 20 Nov 2021 01:43)
Your stance is confusing. You told me you were JUST talking about the House. Which is it?
You were arguing that my proposal of putting forward a clean, standalone prescription drug price bill was not possible because you can only use reconciliation once per year. I said that this is not an argument for why the House MUST stick with shitty omnibus bills which are easy to vote down for Republicans. That part of our debate was about legislative tactics.
Then, you opened a different discussion saying that such a standalone bill would be a waste of time because Democrats will get the same thing enacted anyway with their current strategy of the big omnibus bill, which is not true because the BBB bill will be renegotiated in the Senate before Manchin and Sinema give it the thumbs up. Given Sinema's opposition against this very provision and her ties to big pharma, it's well possible that a modified version of BBB ultimately passes, but with the prescription drug price regulations either left out or gutted.
My point is that by using the omnibus bill framework, Democrats are giving both Republicans and Sinema more cover to shoot down this very popular policy which imho would have a better chance of becoming law as a standalone bill.
Quote (NetflixAdaptationWidow @ 20 Nov 2021 01:51)
Black: of course it's unpopular when you make an actual proposal. People like unspecified bills. When you poll on the real issue it goes down.
Also Black: If they just made a real bill it would definitely still have 80% support.
Jesus fuck dude, that's one of the most low IQ takes I've seen you make in a long long time.
Almost all policies are a tradeoff between competing interests. They have their pros and cons, give group A something while taking away something from group B. That's why policies which sound good in abstract typically see their popularity go down once the specifics become clearer, because that's when people realize that they would belong to group B.
Prescription drug price regulations are a huge and obvious exception in this regard because only big pharma belongs to group B while everyone else would be left off better.
This post was edited by Black XistenZ on Nov 19 2021 07:06pm